Síguenos en Twitter       Síguenos en Facebook       Síguenos en YouTube       Siguenos en Linkedin       Correo Grupsagessa       Gmail       Yahoo Mail       Dropbox       Instagram       Pinterest       Slack       Google Drive       Print       StumbleUpon NEW

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

EMERGENCY MEDICINE DAY: MAY 27

Buscar en contenido

Contenido:

sábado, 7 de julio de 2018

Huntington’s disease

Logo
emDocs - July 4, 2018 - By: McGurk K & Dyer S - Edited by: Koyfman A & Long B
Take Home Points
  • The clinical effects of HD are progressive but develop slowly. New or rapid changes in a patient’s motor function or cognition should prompt consideration of alternative etiologies or concurrent illness.
  • HD patients may present with acute psychiatric symptoms even before the development of motor symptoms. Risperidone is the med of choice for acute psychosis in HD.
  • Patients with HD need to be carefully screened for suicidal ideation. Their risk of suicide is significantly higher than the general population.
  • Use caution before administering succinylcholine as there may be an increased risk of prolonged apnea and muscle paralysis in this patient population. Certain medications, including anticholinergics and metoclopramide, may contribute to worsened chorea.
  • Consider awake fiberoptic intubation when appropriate. Patients with advanced HD have a high risk of aspiration.